BiotechTube
Home/Evozyne/Stephen Wanaski, PhD
SW

Stephen Wanaski, PhD

SVP, Research & Exploratory Development

Evozyne

Therapeutic Areas

Immune-mediated diseases

Evozyne Pipeline

DrugIndicationPhase
IgG ProteasesImmune-mediated diseases (Autoimmune)Pre-clinical
Next-generation CytokinesImmuno-oncology / Inflammatory diseasesPre-clinical
Respiratory Disease CandidatesRespiratory inflammatory diseasesPre-clinical

Leadership Team at Evozyne

MY
Marc Yoskowitz
Chief Executive Officer
AR
Arjun Rallapalli, PhD
Chief Operating Officer
UH
Uri Herzberg, PhD, DVM, MBA
Chief Drug Discovery Officer
View full Evozyne profile